To evaluate age-dependent variations in susceptibility to RSV and their influence on transmission dynamics and the impact of immunization programs, emphasizing the significance of these variations.
Key Findings:
RSV hospitalisation rates vary significantly by age, peaking in infants under 6 months, indicating a critical area for intervention.
Young children exhibit higher susceptibility to RSV infections compared to older age groups, underscoring the need for targeted prevention strategies.
Recent RSV prophylaxis developments, including nirsevimab and RSVpreF vaccine, show high efficacy in preventing severe infections, which could reshape immunization approaches.
Interpretation:
Age-dependent susceptibility significantly influences RSV transmission dynamics and the effectiveness of immunization programs, highlighting the need for targeted interventions to improve public health outcomes.
Limitations:
Incomplete ascertainment of RSV infections due to lack of systematic viral testing, which may lead to underestimating the true burden of disease.
Under-representation of asymptomatic and mild infections in routine surveillance data, potentially skewing the understanding of RSV dynamics.
Conclusion:
Understanding age-related vulnerability is crucial for optimizing RSV immunization strategies and improving public health outcomes, particularly through targeted interventions.
